| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/10/2008 | EP1240901B1 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
| 09/10/2008 | CN101263133A New pyridine analogues |
| 09/10/2008 | CN101263115A Substituted indoles and use thereof |
| 09/10/2008 | CN101260150A Ancylostoma caninum anticoagulant peptide and its preparation and application |
| 09/10/2008 | CN101260112A Acethydrazide derivatives containing thieno[3.2-c]pyridine, preparation method and use thereof |
| 09/10/2008 | CN101260104A Inhibition of phosphoinositide 3-kinase beta |
| 09/10/2008 | CN101259285A Application of 2-chitosan salicylic acid graft compound in anticoagulant and long-acting ease pain |
| 09/10/2008 | CN101259248A Aerofloat of Southern Shaanxi |
| 09/10/2008 | CN101259218A Chinese medicine preparation for treating vertigo |
| 09/10/2008 | CN101259190A Chinese medicine assembly for warming kidney, compensating spleen, benefitting qi and nourishing blood and preparation thereof |
| 09/10/2008 | CN101259189A Medicinal composition for treating leukocytopenia and preparation thereof |
| 09/10/2008 | CN101259163A Content detecting method for lamioplomis rotate plaster |
| 09/10/2008 | CN101259150A Sustained-release pellet of ginkgo biloba extract and its preparation |
| 09/10/2008 | CN100417381C Nicorandil freeze-drying powder preparation method |
| 09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423021 Peptidic thrombin inhibitors |
| 09/09/2008 | US7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 09/09/2008 | US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene |
| 09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/04/2008 | WO2008105436A1 TUMOR NECROSIS FACTOR-α INHIBITOR AND PROSTAGLANDIN SYNTHASE-2 INHIBITOR |
| 09/04/2008 | WO2008104620A1 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 09/04/2008 | WO2008104279A1 Imidazo[1,2-a]azines and their use as pharmaceuticals |
| 09/04/2008 | WO2007134813A3 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism |
| 09/04/2008 | US20080214812 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 09/04/2008 | US20080214647 {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid; thrombosis or fibrinolytic impairment is associated with formation of atherosclerotic plaques, venous and arterial thrombosis, myocardial ischemia, atrial fibrillation, deep vein thrombosis, coagulation syndromes |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214630 Desferrithiocin polyether analogues |
| 09/04/2008 | US20080214626 Methods for prevention and treatment of diseases causes by hypertension |
| 09/04/2008 | US20080214549 N-Substituted Glycine Derivatives: Hydroxylase Inhibitors |
| 09/04/2008 | US20080214541 Such as 2-(1-naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; differentiating cells into osteoblast lineage; osteoporosis |
| 09/04/2008 | US20080214533 Anticoagulants, thrombolytic agents; amidating a p-(hydroxy-protected alkylamino)aniline with a (hetero)arylaminocarbonyl-(hetero)aryl carboxylic acid; deblocking, reacting with cyanogen bromide and cyclizing |
| 09/04/2008 | US20080214499 Lowering lipids in a living body by use of a cyclic tetrasaccharide represented by formula of cyclo{>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>}, and/or glycosylated compound(s) thereof |
| 09/04/2008 | US20080214498 Osmotic glucose polymer, electrolyte, and buffer solutions administered to patient after heat sterilization; not subjected to glucose-like degradation during storage and sterilization, and having a pH value in neutral range |
| 09/04/2008 | US20080214483 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 09/04/2008 | US20080214480 Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae |
| 09/04/2008 | US20080214462 FIX-Mutant Proteins for Hemophilia B Treatment |
| 09/04/2008 | US20080214461 FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment |
| 09/04/2008 | US20080214455 5Z)-2-[(2,6-Dichlorophenyl)amino]-5-{[3-(4-morpholinyl)-6-quinoxalinyl]methylidene}-1,3-thiazol-4(5H)-one; inhibiting hYAK3 proteins; autoimmunity, HIV, cancer, drug-induced anemias, myelodysplastic syndrome, aplastic anemia myelosuppression, cytopenia |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213345 Delivering Iron to an Animal |
| 09/04/2008 | US20080213226 Using nitrosomonas mixture in powder, cream, stick and/or salve to oxidize nitric oxide and nitric oxide precursors in order to treat and/or prevent vascular, nervous system, blood and eating disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | CA2679501A1 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals |
| 09/03/2008 | EP1964566A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 09/03/2008 | EP1964556A1 Therapeutic agent or therapeutic method for ischemic stroke |
| 09/03/2008 | EP1962885A2 Method for preparing a factor h concentrate and the use thereof in the form of a drug |
| 09/03/2008 | EP1701933B1 Novel compounds |
| 09/03/2008 | EP1603909A4 Linear chain substituted monocyclic and bicyclic derivatives as factor xa inhibitors |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1311480B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/03/2008 | EP1299424B1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 09/03/2008 | EP1198242B9 Autologous thrombin |
| 09/03/2008 | EP0906340B2 Purification of factor viii complex by immunoaffinity chromatography |
| 09/03/2008 | CN101257908A 腹膜透析液 Peritoneal dialysate |
| 09/03/2008 | CN101255412A Acquisition of antithrombosis small molecule segment by enzyme-restriction of natural lumbrokinase macromolecule |
| 09/03/2008 | CN101255169A Prasugrel salt and preparation method thereof |
| 09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2008 | CN101255149A 7,4'-di(mono succinate)o-ethoxy-daidzein and novel medical uses thereof |
| 09/03/2008 | CN101254275A Chinese medicine for curing aplastic anemia |
| 09/03/2008 | CN101254272A Promoting coronary circulation and embolism resistance medicament |
| 09/03/2008 | CN101254267A Medicament for curing organic lesion of cervix inflammation, metrauxe and the like |
| 09/03/2008 | CN101254210A Gelatine plasma substitutes and method of preparing the same |
| 09/03/2008 | CN101254209A Calf spleen extract injection prepared by inphase opposition column chromatography and preparation thereof |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415252C Chinese medicinal composition for strengthening body and enriching blood and its preparation method |
| 09/03/2008 | CN100415093C Autologous or homologous coagulant produced from anticoagulated whole blood |
| 09/02/2008 | US7420083 For example, (4-{3-[1-(4-tert-butyl-phenyl)-ethylideneaminooxy]-propoxy}-phenyl)-acetic acid; useful for treatment, including the prevention and inhibition, of a wide variety of diseases and disorders including those involving the production and/or action of serine protease inhibitor PAI-1 |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419979 Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one |
| 09/02/2008 | US7419948 Recombinant human Factor IX produced by a transgenic pig having an exogenous DNA stably integrated into its genome that secretes the biologically active Factor into its milk; the factor may be gamma -carboxylated |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | CA2381091C Fat composition |
| 09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008102233A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 08/28/2008 | WO2008102036A1 Method for obtaining a freeze-dried, stable extract from plants of the allium genus |
| 08/28/2008 | WO2008101415A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 08/28/2008 | US20080207902 Phosphodiesterase inhibitors; side effect reduction |
| 08/28/2008 | US20080207878 Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins |
| 08/28/2008 | US20080207695 Thrombin Inhibiting 2-Oxo-1,2,5,6-Tetrahydropyridine Derivatives |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |